I was reading up on this drug called Harmine which is showing promise for enabling beta cells to regrow themselves. Harmine is part of a psychedelic potion used in Ayahuasca ceremonies, which are a centuries’ old ritual of people in the Amazon (the rain forest, not the online retailer).
Beta cells generally don’t proliferate on their own, but Harmine blocks the mechanism that blocks cellular division. Researchers at Mt Sinai School of Medicine are working on drug combos that involve GLP-1 agonists that amplify the effect of Harmine. This shows great promise for Type 2 Diabetes. They are also working on immune suppressors that would allow beta cells to proliferate in Type 1 Diabetes patients. In other words, this could turn out to be a cure for Type 1 Diabetes with a drug that is not under patent. Can you imagine?
If this works as advertised, it’s a Rapamycin-like story of a wonder drug that is under our noses and not patentable, so big pharma is only really interested if they can make a patentable version. The good news here is the Mt Sinai group got an NIH grant to study dosage safety. Hopefully more public money goes into this before Big Pharma figures out how to make the blockbuster drug that cures Type 1 Diabetes and ameliorates advanced Type 2.
Here’s a short write up: Beta Cell Proliferation Research to Investigate Harmine in Phase 1 Trial